2 completed, 2 unknown. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Unknown 2 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow PAD: new trials by email Literature Review of PAD trials Research Report on PAD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Recombinant SeV-hFGF2/dF Injection for PAOD Recombinant SeV-hFGF2/dF Injection - PAOD - Peripheral Arterial Occlusive Disease, PAD | Phase 1 | Unknown | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 12 | 2018-09-05 | 2018-10-25 |
| Arterial Imaging of Inflammation and Resolution After Endovascular Surgery 18F-FDG - Peripheral Arterial Disease, Claudication, Intermittent | Phase 1 | Completed | University of California, San Francisco | 9 | 2017-06-01 | 2020-11-30 |
| Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial unacelyated ghrelin - Peripheral Artery Disease, PAD | Phase 1 / Phase 2 | Completed | Northwestern University | 9 | 2016-06-07 | 2020-03-12 |
| Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD) MultiGeneAngio - PAD, Claudication | Phase 1 / Phase 2 | Unknown | MultiGene Vascular Systems Ltd. | 12 | 2006-10-01 | 2015-03-05 |
Peripheral Arterial Disease (3) · Intermittent Claudication (2) · Arterial Occlusive Diseases (1) · Chronic Limb-Threatening Ischemia (1) · Peripheral Arterial Occlusive Disease 1 (1) · Peripheral Vascular Diseases (1) · Vascular Calcification (1)
Arteriosclerosis (4) · Atherosclerosis (4) · Cardiovascular Diseases (4) · Vascular Diseases (4) · Arterial Occlusive Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Peripheral Vascular Diseases (3) · Signs and Symptoms (2) · Calcinosis (1) · Calcium Metabolism Disorders (1) · Chronic Disease (1) · Disease Attributes (1) · Ischemia (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
MultiGene Vascular Systems Ltd. (1) · Northwestern University (1) · Shenzhen Salubris Pharmaceuticals Co., Ltd. (1) · University of California, San Francisco (1)
United States (3) · China (1)
Mary McDermott, MD (1) · Michael S Conte, M.D. (1) · Miguel H Pampaloni, M.D., PhD. (1) · Sam L Teichman, MD (1)